Anne Husebekk
Corporate Officer/Principal presso University of Tromso
Profilo
Anne Husebekk is the founder of Prophylix AS, which was founded in 2008.
She held the title of Chief Operating Officer & Project Developer.
Currently, she is a Professor & Dean-Scientific Affairs at the University of Tromso.
Dr. Husebekk earned a doctorate degree from the University of Tromso.
Posizioni attive di Anne Husebekk
Società | Posizione | Inizio |
---|---|---|
University of Tromso | Corporate Officer/Principal | - |
Precedenti posizioni note di Anne Husebekk
Società | Posizione | Fine |
---|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Fondatore | - |
Formazione di Anne Husebekk
University of Tromso | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Borsa valori
- Insiders
- Anne Husebekk